MSAT Associate 2
Full-timeEntryCapricor TherapeuticsRare Diseases
$73K - $88K/yr(from employer)
Description
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
The MSAT Associate 2 supports cGMP manufacturing operations through technical writing, investigation management, and process-focused scientific problem solving. This role requires a strong understanding of cell therapy or biologics manufacturing and a demonstrated ability to analyze data, manage quality events, and provide real-time support to production activities.
In this position you will act as a Subject Matter Expert (SME) across manufacturing processes, supporting technology transfer, continuous improvement, deviation investigations, and the development and revision of controlled documentation. This position partners closely with Manufacturing, QA, Process Development, and Supplier Quality to ensure compliant, efficient, and well‑documented operations.
Capricor Therapeutics
BIOTECHNOLOGY
Cell and exosome-based therapies for rare diseases
LocationSAN DIEGO, CA
Open Jobs35
Rare Diseases
View Company ProfilePipeline
CAP-1002 Allogeneic Cardiosphere-Derived CellsN/A
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of FamiliesN/A
Allogeneic Cardiosphere-Derived CellsPhase 1
CAP-1002 Allogeneic Cardiosphere-Derived CellsPhase 1/2
CenderitidePhase 1/2